348 results
424B4
BIOL
Biolase Inc
23 Apr 24
Prospectus supplement with pricing info
4:21pm
;
our failure to comply with existing or new laws and regulations, including fraud and abuse and health information privacy and securities laws
POS AM
BIOL
Biolase Inc
19 Apr 24
Prospectus update (post-effective amendment)
5:07pm
necessary governmental approvals;
our failure to comply with existing or new laws and regulations, including fraud and abuse and health information
POS AM
BIOL
Biolase Inc
11 Apr 24
Prospectus update (post-effective amendment)
4:55pm
or maintain necessary governmental approvals;
our failure to comply with existing or new laws and regulations, including fraud and abuse and health
8-K
EX-10.1
8kyr23
15 Feb 24
BIOLASE, Inc. Announces Pricing of $7.0 Million Public Offering
5:15pm
424B1
s2d iouvdgoa7wkty9
14 Feb 24
Prospectus with pricing info
9:21pm
D
no2l6dq6p
20 Dec 23
$2.73 mm in equity / options / securities to be acquired, sold $2.73 mm, 1 investor
2:13pm
8-K
EX-10.1
t0z0ixq4bc225ej ojg1
8 Dec 23
Biolase, Inc. Announces Pricing of $1.4 Million Registered Direct
9:25am
424B5
yzcpya8 ali1og3
8 Dec 23
Prospectus supplement for primary offering
9:23am